These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17785559)

  • 1. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients.
    Ullenhag GJ; Mukherjee A; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    Clin Cancer Res; 2007 Sep; 13(17):5070-5. PubMed ID: 17785559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
    McCarthy MM; Sznol M; DiVito KA; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jul; 11(14):5188-94. PubMed ID: 16033835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Horak P; Pils D; Kaider A; Pinter A; Elandt K; Sax C; Zielinski CC; Horvat R; Zeillinger R; Reinthaller A; Krainer M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8585-91. PubMed ID: 16361541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome.
    Bagnoli M; Ambrogi F; Pilotti S; Alberti P; Ditto A; Barbareschi M; Galligioni E; Biganzoli E; Canevari S; Mezzanzanica D
    Endocr Relat Cancer; 2009 Jun; 16(2):443-53. PubMed ID: 19321593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
    Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
    Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E
    Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TRAIL system is over-expressed in breast cancer and FLIP a marker of good prognosis.
    Ullenhag GJ; Al-Attar A; Mukherjee A; Green AR; Ellis IO; Durrant LG
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):505-14. PubMed ID: 25230899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of TRAIL and its death receptors in cervical cancer.
    Maduro JH; Noordhuis MG; ten Hoor KA; Pras E; Arts HJ; Eijsink JJ; Hollema H; Mom CH; de Jong S; de Vries EG; de Bock GH; van der Zee AG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):203-11. PubMed ID: 19695437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
    Krajewska M; Kim H; Kim C; Kang H; Welsh K; Matsuzawa S; Tsukamoto M; Thomas RG; Assa-Munt N; Piao Z; Suzuki K; Perucho M; Krajewski S; Reed JC
    Clin Cancer Res; 2005 Aug; 11(15):5451-61. PubMed ID: 16061861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling markers of prognosis in colorectal cancer.
    Lyall MS; Dundas SR; Curran S; Murray GI
    Clin Cancer Res; 2006 Feb; 12(4):1184-91. PubMed ID: 16489072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of TRAIL signalling molecules in cervical squamous cell carcinoma.
    Yao Q; Du J; Lin J; Luo Y; Wang Y; Liu Y; Zhang B; Ren C; Liu C
    J Clin Pathol; 2016 Feb; 69(2):122-7. PubMed ID: 26254281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is C-reactive protein a prognostic factor of colorectal cancer?
    Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
    Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival stratification panel of colorectal carcinoma with combined expression of carcinoembryonic antigen, matrix metalloproteinases-2, and p27 kip1.
    Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
    Dis Colon Rectum; 2007 Nov; 50(11):1887-98. PubMed ID: 17882488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.
    Zhang X; Li W; Olumi AF
    Clin Cancer Res; 2007 Dec; 13(23):7181-90. PubMed ID: 18056199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
    Rolland P; Deen S; Scott I; Durrant L; Spendlove I
    Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming resistance to trail-induced apoptosis in prostate cancer by regulation of c-FLIP.
    Zhang X; Li W; Olumi AF
    Methods Enzymol; 2008; 446():333-49. PubMed ID: 18603132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma.
    Younes M; Georgakis GV; Rahmani M; Beer D; Younes A
    Eur J Cancer; 2006 Mar; 42(4):542-7. PubMed ID: 16426839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.